NCT04496349 2025-11-04A Study Evaluating APG-115 as a Single Agent or in Combination With APG-2575 in Subjects With R/R T-PLL and NHLAscentage Pharma Group Inc.Phase 2 Recruiting78 enrolled
NCT04771572 2024-04-24Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.Newave Pharmaceutical IncPhase 1 Recruiting100 enrolled